Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HCID 2773289Generated: October 23, 2026

6-bromo-2,3-dihydro-1H-indol-2-one

6-bromoindolin-2-one · 6-BROMOOXINDOLE · B71130 · SWF-13 · 6-Bromoxoindole · 6-Bromooxoindole · 6-broMooxiindole · BROMOOXINDOLE (6-)

https://huagongshe.com/en/chemical/2773289

6-bromo-2,3-dihydro-1H-indol-2-one molecular structure

Identifiers & Physical Properties

CAS No.99365-40-9
Molecular formulaC8H6BrNO
Average molar mass212.04 g/mol
Monoisotopic mass210.96328 g/mol
SMILESO=C1Cc2ccc(Br)cc2N1
InChIKeyJARRYVQFBQVOBE-UHFFFAOYSA-N
PubChem CID2773289
ChEMBLCHEMBL2381492
EC No.800-899-7
DTXSIDDTXSID90378341

Chemical & Physical Properties

XLogP1.9
Topological polar surface area29.1
Hydrogen bond donors1
Hydrogen bond acceptors1
Rotatable bonds0
Heavy atoms11
Formal charge0
Complexity183
Melting point217-221 °C(lit.)
Boiling point343.6±42.0 °C(Predicted)
Density1.666±0.06 g/cm3(Predicted)
Storage conditions2-8°C
SolubilityDMSoSlightly soluble in water.
Physical stateSolid
pKa (acidity coefficient)13.39±0.20(Predicted)
ColorOrange
InChIInChI=1S/C8H6BrNO/c9-6-2-1-5-3-8(11)10-7(5)4-6/h1-2,4H,3H2,(H,10,11)
InChIKeyJARRYVQFBQVOBE-UHFFFAOYSA-N
SMILESN1C2=C(C=CC(Br)=C2)CC1=O
CAS DataBase Reference99365-40-9(CAS DataBase Reference)
UNSPSC Code12352100
NACRESNA.22
GHS pictogramGHS06,GHS08,GHS09
Signal wordDanger
GHS hazard statementsH301-H312-H315-H319-H361-H371-H372-H373-H317-H341-H411
GHS precautionary statementsP501-P273-P272-P260-P270-P202-P201-P264-P280-P391-P337+P313-P305+P351+P338-P308+P311-P362+P364-P333+P313-P301+P310+P330-P302+P352+P312-P405
Personal protective equipment (PPE)Eyeshields, Gloves, type N95 (US)
Hazard symbolsXi
Risk statements (R)36/37/38
Safety statements (S)26-36/37/39-24/25
Water hazard class (WGK)3
Hazard NoteIrritant
Customs code29339900
Storage class11 - Combustible Solids

Safety & Regulations

GHS classificationWarningH302 (66.7%): Harmful if swallowed [Warning Acute toxicity, oral]H312 (33.3%): Harmful in contact with skin [Warning Acute toxicity, dermal]H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]H332 (33.3%): Harmful if inhaled [Warning Acute toxicity, inhalation]H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposureRespiratory tract irritation]P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 3 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
Hazard Classes and CategoriesAcute Tox. 4 (66.7%)Acute Tox. 4 (33.3%)Skin Irrit. 2 (100%)Eye Irrit. 2A (100%)STOT SE 3 (100%)
Personal protective equipment (PPE)Eyeshields, Gloves, type N95 (US)
Water hazard class (WGK)3
Customs code29339900
Risk statements (R)36/37/38
Signal wordDanger
GHS pictogramGHS06,GHS08,GHS09
Hazard symbolsXi
hazard_noteIrritant
Safety statements (S)26-36/37/39-24/25
Storage class11 - Combustible Solids
GHS hazard statementsH301-H312-H315-H319-H361-H371-H372-H373-H317-H341-H411
GHS precautionary statementsP501-P273-P272-P260-P270-P202-P201-P264-P280-P391-P337+P313-P305+P351+P338-P308+P311-P362+P364-P333+P313-P301+P310+P330-P302+P352+P312-P405

Applications & Uses

Uses

6-Bromooxindole derivative is used in the preparation of p38alpha inhibitors as potential anti- inflammatories. It is used as an intermediate in pharmaceuticals.

Uses

6-Bromo-2-Oxindole is an indolinone derivative used for the preparation of p38α inhibitors as potential antiinflammatories.